0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Organs-on-Chips Market Research Report 2026
Published Date: 2026-04-22
|
Report Code: QYRE-Auto-39D8996
Home | Market Reports
Global Human Organs on Chips Market Insights and Forecast to 2028
BUY CHAPTERS

Global Human Organs-on-Chips Market Research Report 2026

Code: QYRE-Auto-39D8996
Report
2026-04-22
Pages:139
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Human Organs-on-Chips Market Size

The global Human Organs-on-Chips market was valued at US$ 200 million in 2025 and is anticipated to reach US$ 1306 million by 2032, at a CAGR of 31.2% from 2026 to 2032.

Human Organs-on-Chips Market

Human Organs-on-Chips Market

An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels. The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumours), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney). In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.
Global key players of Human Organs-on-Chips include Emulate, Mimetas, TissUse, Valo Health and CN Bio Innovations. The top five players hold a share over 55%. North America is the largest market, has a share about 42%, followed by Europe, and Asia-Pacific, with share 35% and 18%, separately. In terms of product type, Liver-on-a-chip is the largest segment, occupied for a share of 26%, and in terms of application, Pharmaceutical & Biotechnology Companies has a share about 70%.
This report delivers a comprehensive overview of the global Human Organs-on-Chips market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Human Organs-on-Chips. The Human Organs-on-Chips market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Human Organs-on-Chips market comprehensively. Regional market sizes by Type, by End User, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Human Organs-on-Chips manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by End User, and by region.
Market Segmentation

Scope of Human Organs-on-Chips Market Report

Report Metric Details
Report Name Human Organs-on-Chips Market
Accounted market size in 2025 US$ 200 million
Forecasted market size in 2032 US$ 1306 million
CAGR 31.2%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Brain-on-a-chip
  • Liver-on-a-chip
  • Kidney-on-a-chip
  • Lung-on-a-chip
  • Heart-on-a-chip
  • Intestine-on-a-chip
  • Vessel-on-a-chip
  • Other Organs
Segment by End User
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Cosmetics Industry
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Emulate, Mimetas, TissUse, Valo Health, CN Bio Innovations, Hesperos, Draper Laboratory, Nortis, Micronit Microtechnologies B.V., Kirkstall, Cherry Biotech SAS, Else Kooi Laboratory, Altis Biosystems, Bi/ond, Netri, Xona Microfluidics, SynVivo, Beijing Daxiang Biotech, AVATARGET, Suzhou Jiyan Biopharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by End User, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Human Organs-on-Chips companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by End User, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Human Organs-on-Chips Market growing?

Ans: The Human Organs-on-Chips Market witnessing a CAGR of 31.2% during the forecast period 2026-2032.

What is the Human Organs-on-Chips Market size in 2032?

Ans: The Human Organs-on-Chips Market size in 2032 will be US$ 1306 million.

What is the market share of major companies in Human Organs-on-Chips Market?

Ans: The top five players hold a share over 55%.

What is the Human Organs-on-Chips Market share by region?

Ans: North America is the largest market, has a share about 42%, followed by Europe, and Asia-Pacific, with share 35% and 18%, separately.

What is the Human Organs-on-Chips Market share by type?

Ans: In terms of product type, Liver-on-a-chip is the largest segment, occupied for a share of 26%, and in terms of application, Pharmaceutical & Biotechnology Companies has a share about 70%.

Who are the main players in the Human Organs-on-Chips Market report?

Ans: The main players in the Human Organs-on-Chips Market are Emulate, Mimetas, TissUse, Valo Health, CN Bio Innovations, Hesperos, Draper Laboratory, Nortis, Micronit Microtechnologies B.V., Kirkstall, Cherry Biotech SAS, Else Kooi Laboratory, Altis Biosystems, Bi/ond, Netri, Xona Microfluidics, SynVivo, Beijing Daxiang Biotech, AVATARGET, Suzhou Jiyan Biopharmaceutical

What are the Type segmentation covered in the Human Organs-on-Chips Market report?

Ans: The Types covered in the Human Organs-on-Chips Market report are Brain-on-a-chip, Liver-on-a-chip, Kidney-on-a-chip, Lung-on-a-chip, Heart-on-a-chip, Intestine-on-a-chip, Vessel-on-a-chip, Other Organs

What are the End User segmentation covered in the Human Organs-on-Chips Market report?

Ans: The End users covered in the Human Organs-on-Chips Market report are Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Cosmetics Industry, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Organs-on-Chips Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Brain-on-a-chip
1.2.3 Liver-on-a-chip
1.2.4 Kidney-on-a-chip
1.2.5 Lung-on-a-chip
1.2.6 Heart-on-a-chip
1.2.7 Intestine-on-a-chip
1.2.8 Vessel-on-a-chip
1.2.9 Other Organs
1.3 Market by End User
1.3.1 Global Human Organs-on-Chips Market Growth by End User: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Cosmetics Industry
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Organs-on-Chips Market Perspective (2021–2032)
2.2 Global Human Organs-on-Chips Growth Trends by Region
2.2.1 Global Human Organs-on-Chips Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Human Organs-on-Chips Historic Market Size by Region (2021–2026)
2.2.3 Human Organs-on-Chips Forecasted Market Size by Region (2027–2032)
2.3 Human Organs-on-Chips Market Dynamics
2.3.1 Human Organs-on-Chips Industry Trends
2.3.2 Human Organs-on-Chips Market Drivers
2.3.3 Human Organs-on-Chips Market Challenges
2.3.4 Human Organs-on-Chips Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Organs-on-Chips Players by Revenue
3.1.1 Global Top Human Organs-on-Chips Players by Revenue (2021–2026)
3.1.2 Global Human Organs-on-Chips Revenue Market Share by Players (2021–2026)
3.2 Global Top Human Organs-on-Chips Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Human Organs-on-Chips Revenue
3.4 Global Human Organs-on-Chips Market Concentration Ratio
3.4.1 Global Human Organs-on-Chips Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Organs-on-Chips Revenue in 2025
3.5 Global Key Players of Human Organs-on-Chips Head Offices and Areas Served
3.6 Global Key Players of Human Organs-on-Chips, Products and Applications
3.7 Global Key Players of Human Organs-on-Chips, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Human Organs-on-Chips Breakdown Data by Type
4.1 Global Human Organs-on-Chips Historic Market Size by Type (2021–2026)
4.2 Global Human Organs-on-Chips Forecasted Market Size by Type (2027–2032)
5 Human Organs-on-Chips Breakdown Data by End User
5.1 Global Human Organs-on-Chips Historic Market Size by End User (2021–2026)
5.2 Global Human Organs-on-Chips Forecasted Market Size by End User (2027–2032)
6 North America
6.1 North America Human Organs-on-Chips Market Size (2021–2032)
6.2 North America Human Organs-on-Chips Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Human Organs-on-Chips Market Size by Country (2021–2026)
6.4 North America Human Organs-on-Chips Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Organs-on-Chips Market Size (2021–2032)
7.2 Europe Human Organs-on-Chips Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Human Organs-on-Chips Market Size by Country (2021–2026)
7.4 Europe Human Organs-on-Chips Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Human Organs-on-Chips Market Size (2021–2032)
8.2 Asia-Pacific Human Organs-on-Chips Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Human Organs-on-Chips Market Size by Region (2021–2026)
8.4 Asia-Pacific Human Organs-on-Chips Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Human Organs-on-Chips Market Size (2021–2032)
9.2 Latin America Human Organs-on-Chips Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Human Organs-on-Chips Market Size by Country (2021–2026)
9.4 Latin America Human Organs-on-Chips Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Organs-on-Chips Market Size (2021–2032)
10.2 Middle East & Africa Human Organs-on-Chips Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Human Organs-on-Chips Market Size by Country (2021–2026)
10.4 Middle East & Africa Human Organs-on-Chips Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Emulate
11.1.1 Emulate Company Details
11.1.2 Emulate Business Overview
11.1.3 Emulate Human Organs-on-Chips Introduction
11.1.4 Emulate Revenue in Human Organs-on-Chips Business (2021–2026)
11.1.5 Emulate Recent Development
11.2 Mimetas
11.2.1 Mimetas Company Details
11.2.2 Mimetas Business Overview
11.2.3 Mimetas Human Organs-on-Chips Introduction
11.2.4 Mimetas Revenue in Human Organs-on-Chips Business (2021–2026)
11.2.5 Mimetas Recent Development
11.3 TissUse
11.3.1 TissUse Company Details
11.3.2 TissUse Business Overview
11.3.3 TissUse Human Organs-on-Chips Introduction
11.3.4 TissUse Revenue in Human Organs-on-Chips Business (2021–2026)
11.3.5 TissUse Recent Development
11.4 Valo Health
11.4.1 Valo Health Company Details
11.4.2 Valo Health Business Overview
11.4.3 Valo Health Human Organs-on-Chips Introduction
11.4.4 Valo Health Revenue in Human Organs-on-Chips Business (2021–2026)
11.4.5 Valo Health Recent Development
11.5 CN Bio Innovations
11.5.1 CN Bio Innovations Company Details
11.5.2 CN Bio Innovations Business Overview
11.5.3 CN Bio Innovations Human Organs-on-Chips Introduction
11.5.4 CN Bio Innovations Revenue in Human Organs-on-Chips Business (2021–2026)
11.5.5 CN Bio Innovations Recent Development
11.6 Hesperos
11.6.1 Hesperos Company Details
11.6.2 Hesperos Business Overview
11.6.3 Hesperos Human Organs-on-Chips Introduction
11.6.4 Hesperos Revenue in Human Organs-on-Chips Business (2021–2026)
11.6.5 Hesperos Recent Development
11.7 Draper Laboratory
11.7.1 Draper Laboratory Company Details
11.7.2 Draper Laboratory Business Overview
11.7.3 Draper Laboratory Human Organs-on-Chips Introduction
11.7.4 Draper Laboratory Revenue in Human Organs-on-Chips Business (2021–2026)
11.7.5 Draper Laboratory Recent Development
11.8 Nortis
11.8.1 Nortis Company Details
11.8.2 Nortis Business Overview
11.8.3 Nortis Human Organs-on-Chips Introduction
11.8.4 Nortis Revenue in Human Organs-on-Chips Business (2021–2026)
11.8.5 Nortis Recent Development
11.9 Micronit Microtechnologies B.V.
11.9.1 Micronit Microtechnologies B.V. Company Details
11.9.2 Micronit Microtechnologies B.V. Business Overview
11.9.3 Micronit Microtechnologies B.V. Human Organs-on-Chips Introduction
11.9.4 Micronit Microtechnologies B.V. Revenue in Human Organs-on-Chips Business (2021–2026)
11.9.5 Micronit Microtechnologies B.V. Recent Development
11.10 Kirkstall
11.10.1 Kirkstall Company Details
11.10.2 Kirkstall Business Overview
11.10.3 Kirkstall Human Organs-on-Chips Introduction
11.10.4 Kirkstall Revenue in Human Organs-on-Chips Business (2021–2026)
11.10.5 Kirkstall Recent Development
11.11 Cherry Biotech SAS
11.11.1 Cherry Biotech SAS Company Details
11.11.2 Cherry Biotech SAS Business Overview
11.11.3 Cherry Biotech SAS Human Organs-on-Chips Introduction
11.11.4 Cherry Biotech SAS Revenue in Human Organs-on-Chips Business (2021–2026)
11.11.5 Cherry Biotech SAS Recent Development
11.12 Else Kooi Laboratory
11.12.1 Else Kooi Laboratory Company Details
11.12.2 Else Kooi Laboratory Business Overview
11.12.3 Else Kooi Laboratory Human Organs-on-Chips Introduction
11.12.4 Else Kooi Laboratory Revenue in Human Organs-on-Chips Business (2021–2026)
11.12.5 Else Kooi Laboratory Recent Development
11.13 Altis Biosystems
11.13.1 Altis Biosystems Company Details
11.13.2 Altis Biosystems Business Overview
11.13.3 Altis Biosystems Human Organs-on-Chips Introduction
11.13.4 Altis Biosystems Revenue in Human Organs-on-Chips Business (2021–2026)
11.13.5 Altis Biosystems Recent Development
11.14 Bi/ond
11.14.1 Bi/ond Company Details
11.14.2 Bi/ond Business Overview
11.14.3 Bi/ond Human Organs-on-Chips Introduction
11.14.4 Bi/ond Revenue in Human Organs-on-Chips Business (2021–2026)
11.14.5 Bi/ond Recent Development
11.15 Netri
11.15.1 Netri Company Details
11.15.2 Netri Business Overview
11.15.3 Netri Human Organs-on-Chips Introduction
11.15.4 Netri Revenue in Human Organs-on-Chips Business (2021–2026)
11.15.5 Netri Recent Development
11.16 Xona Microfluidics
11.16.1 Xona Microfluidics Company Details
11.16.2 Xona Microfluidics Business Overview
11.16.3 Xona Microfluidics Human Organs-on-Chips Introduction
11.16.4 Xona Microfluidics Revenue in Human Organs-on-Chips Business (2021–2026)
11.16.5 Xona Microfluidics Recent Development
11.17 SynVivo
11.17.1 SynVivo Company Details
11.17.2 SynVivo Business Overview
11.17.3 SynVivo Human Organs-on-Chips Introduction
11.17.4 SynVivo Revenue in Human Organs-on-Chips Business (2021–2026)
11.17.5 SynVivo Recent Development
11.18 Beijing Daxiang Biotech
11.18.1 Beijing Daxiang Biotech Company Details
11.18.2 Beijing Daxiang Biotech Business Overview
11.18.3 Beijing Daxiang Biotech Human Organs-on-Chips Introduction
11.18.4 Beijing Daxiang Biotech Revenue in Human Organs-on-Chips Business (2021–2026)
11.18.5 Beijing Daxiang Biotech Recent Development
11.19 AVATARGET
11.19.1 AVATARGET Company Details
11.19.2 AVATARGET Business Overview
11.19.3 AVATARGET Human Organs-on-Chips Introduction
11.19.4 AVATARGET Revenue in Human Organs-on-Chips Business (2021–2026)
11.19.5 AVATARGET Recent Development
11.20 Suzhou Jiyan Biopharmaceutical
11.20.1 Suzhou Jiyan Biopharmaceutical Company Details
11.20.2 Suzhou Jiyan Biopharmaceutical Business Overview
11.20.3 Suzhou Jiyan Biopharmaceutical Human Organs-on-Chips Introduction
11.20.4 Suzhou Jiyan Biopharmaceutical Revenue in Human Organs-on-Chips Business (2021–2026)
11.20.5 Suzhou Jiyan Biopharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Human Organs-on-Chips Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Brain-on-a-chip
 Table 3. Key Players of Liver-on-a-chip
 Table 4. Key Players of Kidney-on-a-chip
 Table 5. Key Players of Lung-on-a-chip
 Table 6. Key Players of Heart-on-a-chip
 Table 7. Key Players of Intestine-on-a-chip
 Table 8. Key Players of Vessel-on-a-chip
 Table 9. Global Human Organs-on-Chips Market Size Growth by End User (US$ Million): 2021 vs 2025 vs 2032
 Table 10. Global Human Organs-on-Chips Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 11. Global Human Organs-on-Chips Market Size by Region (US$ Million), 2021–2026
 Table 12. Global Human Organs-on-Chips Market Share by Region (2021–2026)
 Table 13. Global Human Organs-on-Chips Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 14. Global Human Organs-on-Chips Market Share by Region (2027–2032)
 Table 15. Human Organs-on-Chips Market Trends
 Table 16. Human Organs-on-Chips Market Drivers
 Table 17. Human Organs-on-Chips Market Challenges
 Table 18. Human Organs-on-Chips Market Restraints
 Table 19. Global Human Organs-on-Chips Revenue by Players (US$ Million), 2021–2026
 Table 20. Global Human Organs-on-Chips Market Share by Players (2021–2026)
 Table 21. Global Top Human Organs-on-Chips Players by Tier (Tier 1, Tier 2, and Tier 3), based on Human Organs-on-Chips Revenue, 2025
 Table 22. Ranking of Global Top Human Organs-on-Chips Companies by Revenue (US$ Million) in 2025
 Table 23. Global 5 Largest Players Market Share by Human Organs-on-Chips Revenue (CR5 and HHI), 2021–2026
 Table 24. Global Key Players of Human Organs-on-Chips, Headquarters and Area Served
 Table 25. Global Key Players of Human Organs-on-Chips, Products and Applications
 Table 26. Global Key Players of Human Organs-on-Chips, Date of General Availability (GA)
 Table 27. Mergers and Acquisitions, Expansion Plans
 Table 28. Global Human Organs-on-Chips Market Size by Type (US$ Million), 2021–2026
 Table 29. Global Human Organs-on-Chips Revenue Market Share by Type (2021–2026)
 Table 30. Global Human Organs-on-Chips Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 31. Global Human Organs-on-Chips Revenue Market Share by Type (2027–2032)
 Table 32. Global Human Organs-on-Chips Market Size by End User (US$ Million), 2021–2026
 Table 33. Global Human Organs-on-Chips Revenue Market Share by End User (2021–2026)
 Table 34. Global Human Organs-on-Chips Forecasted Market Size by End User (US$ Million), 2027–2032
 Table 35. Global Human Organs-on-Chips Revenue Market Share by End User (2027–2032)
 Table 36. North America Human Organs-on-Chips Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. North America Human Organs-on-Chips Market Size by Country (US$ Million), 2021–2026
 Table 38. North America Human Organs-on-Chips Market Size by Country (US$ Million), 2027–2032
 Table 39. Europe Human Organs-on-Chips Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Europe Human Organs-on-Chips Market Size by Country (US$ Million), 2021–2026
 Table 41. Europe Human Organs-on-Chips Market Size by Country (US$ Million), 2027–2032
 Table 42. Asia-Pacific Human Organs-on-Chips Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Asia-Pacific Human Organs-on-Chips Market Size by Region (US$ Million), 2021–2026
 Table 44. Asia-Pacific Human Organs-on-Chips Market Size by Region (US$ Million), 2027–2032
 Table 45. Latin America Human Organs-on-Chips Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Latin America Human Organs-on-Chips Market Size by Country (US$ Million), 2021–2026
 Table 47. Latin America Human Organs-on-Chips Market Size by Country (US$ Million), 2027–2032
 Table 48. Middle East & Africa Human Organs-on-Chips Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 49. Middle East & Africa Human Organs-on-Chips Market Size by Country (US$ Million), 2021–2026
 Table 50. Middle East & Africa Human Organs-on-Chips Market Size by Country (US$ Million), 2027–2032
 Table 51. Emulate Company Details
 Table 52. Emulate Business Overview
 Table 53. Emulate Human Organs-on-Chips Product
 Table 54. Emulate Revenue in Human Organs-on-Chips Business (US$ Million), 2021–2026
 Table 55. Emulate Recent Development
 Table 56. Mimetas Company Details
 Table 57. Mimetas Business Overview
 Table 58. Mimetas Human Organs-on-Chips Product
 Table 59. Mimetas Revenue in Human Organs-on-Chips Business (US$ Million), 2021–2026
 Table 60. Mimetas Recent Development
 Table 61. TissUse Company Details
 Table 62. TissUse Business Overview
 Table 63. TissUse Human Organs-on-Chips Product
 Table 64. TissUse Revenue in Human Organs-on-Chips Business (US$ Million), 2021–2026
 Table 65. TissUse Recent Development
 Table 66. Valo Health Company Details
 Table 67. Valo Health Business Overview
 Table 68. Valo Health Human Organs-on-Chips Product
 Table 69. Valo Health Revenue in Human Organs-on-Chips Business (US$ Million), 2021–2026
 Table 70. Valo Health Recent Development
 Table 71. CN Bio Innovations Company Details
 Table 72. CN Bio Innovations Business Overview
 Table 73. CN Bio Innovations Human Organs-on-Chips Product
 Table 74. CN Bio Innovations Revenue in Human Organs-on-Chips Business (US$ Million), 2021–2026
 Table 75. CN Bio Innovations Recent Development
 Table 76. Hesperos Company Details
 Table 77. Hesperos Business Overview
 Table 78. Hesperos Human Organs-on-Chips Product
 Table 79. Hesperos Revenue in Human Organs-on-Chips Business (US$ Million), 2021–2026
 Table 80. Hesperos Recent Development
 Table 81. Draper Laboratory Company Details
 Table 82. Draper Laboratory Business Overview
 Table 83. Draper Laboratory Human Organs-on-Chips Product
 Table 84. Draper Laboratory Revenue in Human Organs-on-Chips Business (US$ Million), 2021–2026
 Table 85. Draper Laboratory Recent Development
 Table 86. Nortis Company Details
 Table 87. Nortis Business Overview
 Table 88. Nortis Human Organs-on-Chips Product
 Table 89. Nortis Revenue in Human Organs-on-Chips Business (US$ Million), 2021–2026
 Table 90. Nortis Recent Development
 Table 91. Micronit Microtechnologies B.V. Company Details
 Table 92. Micronit Microtechnologies B.V. Business Overview
 Table 93. Micronit Microtechnologies B.V. Human Organs-on-Chips Product
 Table 94. Micronit Microtechnologies B.V. Revenue in Human Organs-on-Chips Business (US$ Million), 2021–2026
 Table 95. Micronit Microtechnologies B.V. Recent Development
 Table 96. Kirkstall Company Details
 Table 97. Kirkstall Business Overview
 Table 98. Kirkstall Human Organs-on-Chips Product
 Table 99. Kirkstall Revenue in Human Organs-on-Chips Business (US$ Million), 2021–2026
 Table 100. Kirkstall Recent Development
 Table 101. Cherry Biotech SAS Company Details
 Table 102. Cherry Biotech SAS Business Overview
 Table 103. Cherry Biotech SAS Human Organs-on-Chips Product
 Table 104. Cherry Biotech SAS Revenue in Human Organs-on-Chips Business (US$ Million), 2021–2026
 Table 105. Cherry Biotech SAS Recent Development
 Table 106. Else Kooi Laboratory Company Details
 Table 107. Else Kooi Laboratory Business Overview
 Table 108. Else Kooi Laboratory Human Organs-on-Chips Product
 Table 109. Else Kooi Laboratory Revenue in Human Organs-on-Chips Business (US$ Million), 2021–2026
 Table 110. Else Kooi Laboratory Recent Development
 Table 111. Altis Biosystems Company Details
 Table 112. Altis Biosystems Business Overview
 Table 113. Altis Biosystems Human Organs-on-Chips Product
 Table 114. Altis Biosystems Revenue in Human Organs-on-Chips Business (US$ Million), 2021–2026
 Table 115. Altis Biosystems Recent Development
 Table 116. Bi/ond Company Details
 Table 117. Bi/ond Business Overview
 Table 118. Bi/ond Human Organs-on-Chips Product
 Table 119. Bi/ond Revenue in Human Organs-on-Chips Business (US$ Million), 2021–2026
 Table 120. Bi/ond Recent Development
 Table 121. Netri Company Details
 Table 122. Netri Business Overview
 Table 123. Netri Human Organs-on-Chips Product
 Table 124. Netri Revenue in Human Organs-on-Chips Business (US$ Million), 2021–2026
 Table 125. Netri Recent Development
 Table 126. Xona Microfluidics Company Details
 Table 127. Xona Microfluidics Business Overview
 Table 128. Xona Microfluidics Human Organs-on-Chips Product
 Table 129. Xona Microfluidics Revenue in Human Organs-on-Chips Business (US$ Million), 2021–2026
 Table 130. Xona Microfluidics Recent Development
 Table 131. SynVivo Company Details
 Table 132. SynVivo Business Overview
 Table 133. SynVivo Human Organs-on-Chips Product
 Table 134. SynVivo Revenue in Human Organs-on-Chips Business (US$ Million), 2021–2026
 Table 135. SynVivo Recent Development
 Table 136. Beijing Daxiang Biotech Company Details
 Table 137. Beijing Daxiang Biotech Business Overview
 Table 138. Beijing Daxiang Biotech Human Organs-on-Chips Product
 Table 139. Beijing Daxiang Biotech Revenue in Human Organs-on-Chips Business (US$ Million), 2021–2026
 Table 140. Beijing Daxiang Biotech Recent Development
 Table 141. AVATARGET Company Details
 Table 142. AVATARGET Business Overview
 Table 143. AVATARGET Human Organs-on-Chips Product
 Table 144. AVATARGET Revenue in Human Organs-on-Chips Business (US$ Million), 2021–2026
 Table 145. AVATARGET Recent Development
 Table 146. Suzhou Jiyan Biopharmaceutical Company Details
 Table 147. Suzhou Jiyan Biopharmaceutical Business Overview
 Table 148. Suzhou Jiyan Biopharmaceutical Human Organs-on-Chips Product
 Table 149. Suzhou Jiyan Biopharmaceutical Revenue in Human Organs-on-Chips Business (US$ Million), 2021–2026
 Table 150. Suzhou Jiyan Biopharmaceutical Recent Development
 Table 151. Research Programs/Design for This Report
 Table 152. Key Data Information from Secondary Sources
 Table 153. Key Data Information from Primary Sources
 Table 154. Authors List of This Report


List of Figures
 Figure 1. Human Organs-on-Chips Picture
 Figure 2. Global Human Organs-on-Chips Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Human Organs-on-Chips Market Share by Type: 2025 vs 2032
 Figure 4. Brain-on-a-chip Features
 Figure 5. Liver-on-a-chip Features
 Figure 6. Kidney-on-a-chip Features
 Figure 7. Lung-on-a-chip Features
 Figure 8. Heart-on-a-chip Features
 Figure 9. Intestine-on-a-chip Features
 Figure 10. Vessel-on-a-chip Features
 Figure 11. Other Organs Features
 Figure 12. Global Human Organs-on-Chips Market Size by End User (US$ Million), 2021–2032
 Figure 13. Global Human Organs-on-Chips Market Share by End User: 2025 vs 2032
 Figure 14. Pharmaceutical & Biotechnology Companies Case Studies
 Figure 15. Academic & Research Institutes Case Studies
 Figure 16. Cosmetics Industry Case Studies
 Figure 17. Others Case Studies
 Figure 18. Human Organs-on-Chips Report Years Considered
 Figure 19. Global Human Organs-on-Chips Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 20. Global Human Organs-on-Chips Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 21. Global Human Organs-on-Chips Market Share by Region: 2025 vs 2032
 Figure 22. Global Human Organs-on-Chips Market Share by Players in 2025
 Figure 23. Global Human Organs-on-Chips Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 24. The Top 10 and 5 Players Market Share by Human Organs-on-Chips Revenue in 2025
 Figure 25. North America Human Organs-on-Chips Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. North America Human Organs-on-Chips Market Share by Country (2021–2032)
 Figure 27. United States Human Organs-on-Chips Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Canada Human Organs-on-Chips Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Europe Human Organs-on-Chips Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Europe Human Organs-on-Chips Market Share by Country (2021–2032)
 Figure 31. Germany Human Organs-on-Chips Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. France Human Organs-on-Chips Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. U.K. Human Organs-on-Chips Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Italy Human Organs-on-Chips Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Russia Human Organs-on-Chips Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Ireland Human Organs-on-Chips Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Asia-Pacific Human Organs-on-Chips Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Asia-Pacific Human Organs-on-Chips Market Share by Region (2021–2032)
 Figure 39. China Human Organs-on-Chips Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Japan Human Organs-on-Chips Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. South Korea Human Organs-on-Chips Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Southeast Asia Human Organs-on-Chips Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. India Human Organs-on-Chips Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Australia & New Zealand Human Organs-on-Chips Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Latin America Human Organs-on-Chips Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Latin America Human Organs-on-Chips Market Share by Country (2021–2032)
 Figure 47. Mexico Human Organs-on-Chips Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Brazil Human Organs-on-Chips Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Middle East & Africa Human Organs-on-Chips Market Size YoY Growth (US$ Million), 2021–2032
 Figure 50. Middle East & Africa Human Organs-on-Chips Market Share by Country (2021–2032)
 Figure 51. Israel Human Organs-on-Chips Market Size YoY Growth (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Human Organs-on-Chips Market Size YoY Growth (US$ Million), 2021–2032
 Figure 53. UAE Human Organs-on-Chips Market Size YoY Growth (US$ Million), 2021–2032
 Figure 54. Emulate Revenue Growth Rate in Human Organs-on-Chips Business (2021–2026)
 Figure 55. Mimetas Revenue Growth Rate in Human Organs-on-Chips Business (2021–2026)
 Figure 56. TissUse Revenue Growth Rate in Human Organs-on-Chips Business (2021–2026)
 Figure 57. Valo Health Revenue Growth Rate in Human Organs-on-Chips Business (2021–2026)
 Figure 58. CN Bio Innovations Revenue Growth Rate in Human Organs-on-Chips Business (2021–2026)
 Figure 59. Hesperos Revenue Growth Rate in Human Organs-on-Chips Business (2021–2026)
 Figure 60. Draper Laboratory Revenue Growth Rate in Human Organs-on-Chips Business (2021–2026)
 Figure 61. Nortis Revenue Growth Rate in Human Organs-on-Chips Business (2021–2026)
 Figure 62. Micronit Microtechnologies B.V. Revenue Growth Rate in Human Organs-on-Chips Business (2021–2026)
 Figure 63. Kirkstall Revenue Growth Rate in Human Organs-on-Chips Business (2021–2026)
 Figure 64. Cherry Biotech SAS Revenue Growth Rate in Human Organs-on-Chips Business (2021–2026)
 Figure 65. Else Kooi Laboratory Revenue Growth Rate in Human Organs-on-Chips Business (2021–2026)
 Figure 66. Altis Biosystems Revenue Growth Rate in Human Organs-on-Chips Business (2021–2026)
 Figure 67. Bi/ond Revenue Growth Rate in Human Organs-on-Chips Business (2021–2026)
 Figure 68. Netri Revenue Growth Rate in Human Organs-on-Chips Business (2021–2026)
 Figure 69. Xona Microfluidics Revenue Growth Rate in Human Organs-on-Chips Business (2021–2026)
 Figure 70. SynVivo Revenue Growth Rate in Human Organs-on-Chips Business (2021–2026)
 Figure 71. Beijing Daxiang Biotech Revenue Growth Rate in Human Organs-on-Chips Business (2021–2026)
 Figure 72. AVATARGET Revenue Growth Rate in Human Organs-on-Chips Business (2021–2026)
 Figure 73. Suzhou Jiyan Biopharmaceutical Revenue Growth Rate in Human Organs-on-Chips Business (2021–2026)
 Figure 74. Bottom-up and Top-down Approaches for This Report
 Figure 75. Data Triangulation
 Figure 76. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India